Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer
NCT02386709
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
275
Enrollment
OTHER
Sponsor class
Conditions
FDG PET
Interventions
DEVICE:
FDG PET
Sponsor
Centre Georges Francois Leclerc